Uploaded August 2023 | Updated November 2026, 7 hours ago
The Introduction to the Principles and Practice of Clinical Research (IPPCR) is a course to train participants on how to effectively conduct clinical research. The course focuses on the spectrum of clinical research and the research process by highlighting epidemiologic methods, study design, protocol preparation, patient monitoring, quality assurance, and Food and Drug Administration (FDA) issues.
Stacey Arnold, Ph.D.
The Introduction to the Principles and Practice of Clinical Research (IPPCR) is a course to train participants on how to effectively conduct clinical research. The course focuses on the spectrum of clinical research and the research process by highlighting epidemiologic methods, study design, protocol preparation, patient monitoring, quality assurance, and Food and Drug Administration (FDA) issues.
Stacey Arnold, Ph.D.





![Charting the Path for Alzheimers Prevention
Air date: Wednesday, June 8, 2022, 3:00:00 PM
Description: NIH Director’s Wednesday Afternoon Lecture Series [WALS]
Title: Charting the Path for Alzheimers Prevention with the Colombian Kindred with Autosomal Dominant Alzheimers Disease
Florence Mahoney Lecture on Aging.
Quiroz will discuss how longitudinal studies conducted with Colombian families with autosomal dominant Alzheimers disease have informed biomarker research, disease prevention, and treatment development.
An associate professor in the Departments of Psychiatry and Neurology at Massachusetts General Hospital, Harvard Medical School, Quiroz currently serves as director of the MGH Multicultural Assessment and Research Center and the Multicultural Alzheimers Prevention Program-MAPP. She is also principal investigator on the NIH-funded COLBOS (COLombia-BOSton) biomarker study that follows individuals from the worlds largest extended family with a single, Alzheimers-causing mutation (E280A in Presenilin1).
Her findings have helped researchers re-conceptualize Alzheimers as a sequence of changes that begins decades before cognitive decline, and which may be targeted by promising disease-slowing treatments and prevention strategies at a time in which they might have their most profound effect.
Quiroz hails from Colombia, South America, where she earned her bachelors degree from the University of Antioquia, Medellin, Colombia. She also holds a Masters in Cognitive Neuroscience and Ph.D. in Clinical Psychology, both from Boston University. Her postdoctoral training was in Clinical Neuropsychology, Department of Neurology and Psychiatry, at Massachusetts General Hospital; where she joined the faculty of Harvard Medical School/Massachusetts General Hospital where she remains.
Quiroz has been recognized broadly for her research, including with the NIH Directors Early Independence Award, an MGH Research Scholar Award, and the Alzheimer Associations Inge Grundke-Iqbal Award for Alzheimers Research.
The NIH Mahoney lecture is named in honor of Florence Stephenson Mahoney (1899–2002), who devoted much of her life to successfully advocating for the creation of NIA and increased support for NIH.
For more information go to https://oir.nih.gov/wals
Author: Yakeel T. Quiroz, Ph.D., Associate Professor, Departments of Psychiatry and Neurology, Harvard Medical School
Permanent link: https://videocast.nih.gov/watch=44272 Charting the Path for Alzheimers Prevention](https://i.ytimg.com/vi/JVGYjY39tZc/mqdefault.jpg)




